Chemotherapy-induced amenorrhea, menopause-specific quality of life, and endocrine profiles in premenopausal women with breast cancer who received adjuvant anthracycline-based chemotherapy: a prospective cohort study

[1] Siegel R(2012)Cancer statistics, 2012 CA Cancer J Clin 62 10-29

[2] Naishadham D(2005)Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials Lancet 365 1687-1717

[3] Jemal A(2005)Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005 Ann Oncol 16 1569-1583

[4] Goldhirsch A(2006)Amenorrhea in premenopausal women after adjuvant chemotherapy for breast cancer J Clin Oncol 24 5769-5779

[5] Glick JH(1998)Life after breast cancer: understanding women’s health-related quality of life and sexual functioning J Clin Oncol 16 501-514

[6] Gelber RD(1995)Prevalence of menopausal symptoms among women with a history of breast cancer and attitudes toward estrogen replacement therapy J Clin Oncol 13 2737-2744

[7] Coates AS(2010)Cancer statistics in Korea: incidence, mortality and survival in 2006-2007 J Korean Med Sci 25 1113-1121

[8] Thurlimann B(2005)Incidence and prognostic impact of amenorrhea during adjuvant therapy in high-risk premenopausal breast cancer: analysis of a National Cancer Institute of Canada Clinical Trials Group Study–NCIC CTG MA.5 J Clin Oncol 23 6002-6008

[9] Senn HJ(1996)A menopause-specific quality of life questionnaire: development and psychometric properties Maturitas 24 161-175

[10] Walshe JM(2005)Literature review of instruments to assess health-related quality of life during and after menopause Qual Life Res 14 309-327

[1] Siegel R(2012)Cancer statistics, 2012 CA Cancer J Clin 62 10-29

[2] Naishadham D(2005)Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials Lancet 365 1687-1717

[3] Jemal A(2005)Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005 Ann Oncol 16 1569-1583

[4] Goldhirsch A(2006)Amenorrhea in premenopausal women after adjuvant chemotherapy for breast cancer J Clin Oncol 24 5769-5779

[5] Glick JH(1998)Life after breast cancer: understanding women’s health-related quality of life and sexual functioning J Clin Oncol 16 501-514

[6] Gelber RD(1995)Prevalence of menopausal symptoms among women with a history of breast cancer and attitudes toward estrogen replacement therapy J Clin Oncol 13 2737-2744

[7] Coates AS(2010)Cancer statistics in Korea: incidence, mortality and survival in 2006-2007 J Korean Med Sci 25 1113-1121

[8] Thurlimann B(2005)Incidence and prognostic impact of amenorrhea during adjuvant therapy in high-risk premenopausal breast cancer: analysis of a National Cancer Institute of Canada Clinical Trials Group Study–NCIC CTG MA.5 J Clin Oncol 23 6002-6008

[9] Senn HJ(1996)A menopause-specific quality of life questionnaire: development and psychometric properties Maturitas 24 161-175

[10] Walshe JM(2005)Literature review of instruments to assess health-related quality of life during and after menopause Qual Life Res 14 309-327